Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Net Cash Flow (2017 - 2025)

Neuronetics (STIM) has disclosed Net Cash Flow for 9 consecutive years, with -$319000.0 as the latest value for Q4 2025.

  • Quarterly Net Cash Flow rose 77.34% to -$319000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.7 million through Dec 2025, up 161.54% year-over-year, with the annual reading at $14.7 million for FY2025, 136.49% up from the prior year.
  • Net Cash Flow for Q4 2025 was -$319000.0 at Neuronetics, down from $17.0 million in the prior quarter.
  • The five-year high for Net Cash Flow was $72.3 million in Q1 2021, with the low at -$16.3 million in Q3 2021.
  • Average Net Cash Flow over 5 years is $80450.0, with a median of -$5.2 million recorded in 2021.
  • Peak annual rise in Net Cash Flow hit 819.13% in 2023, while the deepest fall reached 463.5% in 2023.
  • Over 5 years, Net Cash Flow stood at -$5.3 million in 2021, then skyrocketed by 37.5% to -$3.3 million in 2022, then surged by 819.13% to $23.9 million in 2023, then plummeted by 105.9% to -$1.4 million in 2024, then soared by 77.34% to -$319000.0 in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at -$319000.0, $17.0 million, and -$3.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.